Human adipose-derived stromal/stem cells induce functional CD4 +CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions

Stem Cells and Development

Volumn 23, Issue 9, 2014, Pages 968-977

  Frazier, Trivia P ^a   McLachlan, James B ^a   Gimble, Jeffrey M ^b   Tucker, Hugh A ^a   Rowan, Brian G ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; OXYGEN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR ALPHA;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ADIPOSE TISSUE; ADULT; CELL HYPOXIA; CLINICAL TRIAL; CYTOLOGY; FEMALE; IMMUNOLOGY; MESENCHYMAL STROMA CELL;

ADIPOSE TISSUE; ADULT; ANTIGENS, CD4; CELL HYPOXIA; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84899056689     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0152     Document Type: Article

References (56)

1. Cherubino M and KG Marra. (2009). Adipose-derived stem cells for soft tissue regeneration. Regen Med 9:109-117.
2. Gimble JM, AJ Katz and BA Bunnell. (2007). Adiposederived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
3. Moioli EK, M Chen, R Yang, B Shah, J Wu and JJ Mao. (2010). Hybrid adipogenic implants from adipose stem cells for soft tissue reconstruction in vivo. Tissue Eng Part A 16:3299-3307.
4. Yoshimuro K. (2010). Hybrid adipogenic implants from adipose stem cells for soft tissue reconstruction in vivo. Tissue Eng Part A 16:3299-3307.
5. Abumaree M, JM Al, RA Pace and B Kalionis. (2011). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 2:375-392.
6. Singer NG and AI Caplan. (2011). Mesenchymal stem cells mechanisms of inflammation. Annu Rev Pathol 6:457-478.
7. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans, W Weimar and MJ Hoogduijn. (2010). Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19:1843-1853.
8. Wang JA, A He, X Hu, Y Jiang, Y Sun, J Jiang, C Gui, Y Wang and H Chen. (2009). Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. Int J Cardiol 133:410-412.
9. Delarosa O, B Sanchez-Correa, S Morgado, C Ramirez, RB Del, R Menta, E Lombardo, R Tarazona and JG Casado. (2011). Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev 21:1333-1343.
10. Murphy KM. (2011). Janeway's Immunobiology, 8th edition. Garland Science, New York, NY.
11. Chen W, W Jin, N Hardegen, KJ Lei, L Li, N Marinos, G McGrady and SM Wahl. (2003). Conversion of peripheral CD4 +. J Exp Med 198:1875-1886.
12. Ghannam S, J Pene, G Torcy-Moquet, C Jorgensen and H Yssel. (2010). Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce at regulatory cell phenotype. Immunology 185:302-312.
13. Hegyi B, G Kudlik, E Monostori and F Uher. (2012). Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells. Biochem Biophys Res Commun 419:215-220.
14. Hoogduijn MJ, MJ Crop, AM Peeters, GJ Van Osch, AH Balk, JN Ijzermans, W Weimar and CC Baan. (2007). Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16:597-604.
15. Kronsteiner B, S Wolbank, A Peterbauer, C Hackl, H Redl, M van Griensven and C Gabriel. (2011). Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 20:2115-2126.
16. Marconi S, G Castiglione, E Turano, G Bissolotti, S Angiari, A Farinazzo, G Constantin, G Bedogni, A Bedogni and B Bonetti. (2012). Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A 18:1264-1272.
17. Zhou Y, J Yuan, B Zhou, AJ Lee, AJ Lee, M Ghawji, Jr. and TJ Yoo. (2011). The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology 133:133-140.
18. Muehlberg FL, YH Song, A Krohn, SP Pinilla, LH Droll, X Leng, M Seidensticker, J Ricke, AM Altman, et al. (2009). Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30:589-597.
19. Uccelli A, L Morretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev 9:726-736.
20. De Miguel MP, S Fuentes-Julián, A Blázquez-Martínez, CY Pascual, MA Aller, J Arias and F Arnalich-Montiel. (2012). Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12:574-591.
21. Singer NG and AI Caplan. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457-478.
22. Yanez R, A Oviedo, M Aldea, JA Bueren and ML Lamana. (2010). Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissuederived mesenchymal stromal cells. Exp Cell Res 316: 3109-3123.
23. Kuo YR, CC Chen, S Goto, IT Lee, CW Huang, CC Tsai, CT Wang and CL Chen. (2011). Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg 128:661e-672e.
24. Bilate AM and JJ Lafaille. (2012). Induced CD4 + Foxp3 + regulatory T cells in immune tolerance. Annu Rev Immunol 30:733-758.
25. Engelhardt BG, SM Jagasia, JE Crowe, Jr., ML Griffith, BN Savani, AA Kassim, P Lu, JH Weitkamp, DJ Moore, et al. (2012). Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood 119:2417-2421.
26. Ichihara F, K Kono, A Takahashi, H Kawaida, H Sagai and H Fuji. (2003). Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9:4404-4408.
27. Lanca T and B Silva-Santos. (2012). The split nature of tumor-infiltrating leukocytes implications for cancer surveillance and immunotherapy. Oncoimmunology 1:717-725.
28. Xu L, W Xu, Z Wen and S Xiong. (2011). In situ prior proliferation of CD4 + CCR6 + regulatory T cells facilitated by TGF-b secreting DCs is crucial for their enrichment and suppression in tumor immunity. PLoS One 6:e20282.
29. Zou W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295-307.
30. Henegar C, J Tordjman, V Achard, D Lacasa, I Cremer, M Guerre-Millo, C Poitou, A Basdevant, V Stich, et al. (2008). Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9:R14.
31. Lee EY, Y Xia, WS Kim, MH Kim, TH Kim, KJ Kim, BS Park and JH Sung. (2009). Hypoxia-enhanced woundhealing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17:540-547.
32. Leroux L, B Descamps, NF Tojais, B Seguy, P Oses, C Moreau, D Daret, Z Ivanovic, JM Boiron, et al. (2010). Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther 18:1545-1552.
33. Rosova I, M Dao, B Capoccia, D Link and JA Nolta. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182.
34. Choi EW, IS Shin, SY Park, JH Park, JS Kim, EJ Yoon, SK Kang, JC Ra and SH Hong. (2012). Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 64:243-253.
35. Koenen TB, R Stienstra, LJ van Tits, LA Joosten, JF van Velzen, A Hijmans, JA Pol, JA van der Vliet, MG Netea, et al. (2011). The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology 152:3769-3778.
36. O'Rourke RW, MD Metcalf, AE White, A Madala, BR Winters, II Maizlin, BA Jobe, CT Roberts Jr., MK Slifka and DL Marks. (2009). Depot-specific differences in inflammatory mediators and a role for NK cells and IFNgamma in inflammation in human adipose tissue. Int J Obes (Lond) 33:978-990.
37. O'Rourke RW, AE White, MD Metcalf, AS Olivas, P Mitra, WG Larison, EC Cheang, O Varlamov, CL Corless, CT Roberts Jr. and DL Marks. (2011). Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 54:1480-1490.
38. Razmkhah M, M Jaberipour, N Erfani, M Habibagahi, AR Talei and A Ghaderi. (2011). Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL- 10 and TGF-â1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cell Immunol 2:116-122.
39. Keith B and MC Simon. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465-472.
40. Tremolada C, G Palmieri and C Ricordi. (2010). Adipocyte transplantation and stem cells: plastic surgery meets regenerative medicine. Cell Transplant 19:1217-1223.
41. Frazier TP, JM Gimble, I Kheterpal and BG Rowan. (2013). Impact of low oxygen on the secretome of human adipose-derived stromal/stem cell primary cultures. Biochimie 20:1-11.
42. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans, MSAP Pescatori, WFJ van IJcken, MH Dahlke, E Eggenhofer, W Weimar and MJ Hoogduijn. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol 3:474-486.
43. Bettelli E, Y Carrier, W Gao, T Korn, TB Strom, M Oukka, HL Weiner and VK Kuchroo. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
44. O'Garra A, PL Vieira, P Vieira and AE Goldfeld. (2004). IL-10-producing and naturally occurring CD4 + Tregs: limiting collateral damage. J Clin Invest 114:1372-1378.
45. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans, IP Alwayn, W Weimar and MJ Hoogduijn. (2009). Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 87:896-906.
46. Dons EM, G Raimondi, DK Cooper and A Thomson. (2012). Induced regulatory T cells: mechanisms of conversion and suppressive potential. Hum Immunol 73:328-334.
47. Cipolletta D, D Kolodin, C Benoist and D Mathis. (2011). Tissular T(regs): a unique population of adipose-tissueresident Foxp3 + CD4 + T cells that impacts organismal metabolism. Semin Immunol 23:431-437.
48. Atkuri KR, LA Herzenberg, AK Niemi, T Cowan and LA Herzenberg. (2007). Importance of culturing primary lymphocytes at physiological oxygen levels. Proc Natl Acad Sci U S A 104:4547-4552.
49. Duggan O, P Hyland, K Annett, R Freeburn, C Barnett, G Pawelec and Y Barnett. (2004). Effects of a reduced oxygen tension culture system on human T cell clones as a function of in vitro age. Exp Gerontol 39:525-530.
50. Toussaint O, G Weemaels, F Debacq-Chainiaux, K Scharffetter-Kochanek and M Wlaschek. (2011). Artefactual effects of oxygen on cell culture models of cellular senescence and stem cell biology. J Cell Physiol 226:315-321.
51. Wion D, T Christen, EL Barbier and JA Coles. (2009). PO(2) matters in stem cell culture. Cell Stem Cell 5:242-243.
52. Csete M. (2005). Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 1049:1-8.
53. Sakaguchi S, N Sakaguchi, M Asano, M Itoh and M Toda. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164.
54. Shevach EM. (2000). Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423-449.
55. Vieira PL, JR Christensen, S Minaee, EJ O'Neill, FJ Barrat, A Boonstra, T Barthlott, B Stockinger, DC Wraith and A O'Garra. (2004). IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 + CD25 + regulatory T cells. J Immunol 172:5986-5993.
56. Kim ST, H Jeong, OH Woo, JH Seo, A Kim, ES Lee, SW Shin, YH Kim, JS Kim and KH Park. (2012). Tumorinfiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Am J Clin Oncol 36:224-231.